Alps Medical Breakthroughs Etf Profile
| SBIO Etf | USD 30.55 0.27 0.88% |
PerformanceVery Weak
| Odds Of DistressLow
|
ALPS Medical is selling at 30.55 as of the 23rd of March 2025; that is 0.88 percent decrease since the beginning of the trading day. The etf's open price was 30.82. ALPS Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on May 1, 2023, Senator Thomas R Carper of US Senate acquired under $15k worth of ALPS Medical Breakth's common stock.
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. Alps Medical is traded on NYSEARCA Exchange in the United States. More on ALPS Medical Breakthroughs
Moving together with ALPS Etf
Moving against ALPS Etf
ALPS Etf Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Health Care ETFs, Sector ETFs, Health, ALPS (View all Sectors) |
| Issuer | ALPS |
| Inception Date | 2014-12-31 |
| Benchmark | S-Network Medical Breakthroughs Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 89.43 Million |
| Average Trading Valume | 13,305.6 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | North America |
| Administrator | ALPS Fund Services, Inc. |
| Advisor | ALPS Advisors, Inc. |
| Custodian | State Street Bank and Trust Company |
| Distributor | ALPS Portfolio Solutions Distributor, Inc. |
| Portfolio Manager | Ryan Mischker, Andrew Hicks |
| Transfer Agent | State Street Bank and Trust Company |
| Fiscal Year End | 31-Oct |
| Exchange | NYSE Arca, Inc. |
| Number of Constituents | 105 |
| Market Maker | GTS |
| Total Expense | 0.5 |
| Management Fee | 0.5 |
| Country Name | USA |
| Returns Y T D | (7.51) |
| Name | ALPS Medical Breakthroughs ETF |
| Currency Code | USD |
| Open Figi | BBG007TGGCL0 |
| In Threey Volatility | 27.94 |
| 1y Volatility | 20.14 |
| 200 Day M A | 35.3684 |
| 50 Day M A | 31.6614 |
| Code | SBIO |
| Updated At | 22nd of March 2025 |
| Currency Name | US Dollar |
ALPS Medical Breakthroughs [SBIO] is traded in USA and was established 2014-12-30. The fund is listed under Health category and is part of ALPS family. The entity is thematically classified as Health Care ETFs. ALPS Medical Breakth at this time have 98.57 M in assets. , while the total return for the last 3 years was -1.5%.
Check ALPS Medical Probability Of Bankruptcy
Geographic Allocation (%)
ALPS Medical Breakth Currency Exposure
ALPS Medical Breakthroughs holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of ALPS Medical will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in ALPS Medical Breakthroughs.
Top ALPS Medical Breakthroughs Etf Constituents
| LGND | Ligand Pharmaceuticals Incorporated | Stock | Health Care | |
| ALNY | Alnylam Pharmaceuticals | Stock | Health Care | |
| ALLK | Allakos | Stock | Health Care | |
| EXEL | Exelixis | Stock | Health Care | |
| SWTX | SpringWorks Therapeutics | Stock | Health Care | |
| BLUE | Bluebird bio | Stock | Health Care | |
| HALO | Halozyme Therapeutics | Stock | Health Care | |
| ARRY | Array Technologies | Stock | Industrials |
ALPS Medical Breakth Risk Profiles
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ALPS Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | 1.55 |
ALPS Medical Against Markets
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ALPS Medical Breakthroughs. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
The market value of ALPS Medical Breakth is measured differently than its book value, which is the value of ALPS that is recorded on the company's balance sheet. Investors also form their own opinion of ALPS Medical's value that differs from its market value or its book value, called intrinsic value, which is ALPS Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ALPS Medical's market value can be influenced by many factors that don't directly affect ALPS Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ALPS Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ALPS Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ALPS Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.